{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T08:36:43Z","timestamp":1787819803994,"version":"build-2784847793"},"reference-count":25,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1124\/dmd.115.067405","type":"journal-article","created":{"date-parts":[[2015,10,16]],"date-time":"2015-10-16T01:32:48Z","timestamp":1444959168000},"page":"75-82","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Altered Cisatracurium Pharmacokinetics and Pharmacodynamics in Patients with Congenital Heart Defects"],"prefix":"10.1016","volume":"44","author":[{"given":"Zhufeng","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemei","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunying","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baojian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.115.067405_bib1","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1097\/00000542-199505000-00008","article-title":"The clinical neuromuscular pharmacology of 51W89 in patients receiving nitrous oxide\/opioid\/barbiturate anesthesia","volume":"82","author":"Belmont","year":"1995","journal-title":"Anesthesiology"},{"key":"10.1124\/dmd.115.067405_bib2","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/00000542-200108000-00010","article-title":"Concentration-effect relationship of cisatracurium at three different dose levels in the anesthetized patient","volume":"95","author":"Bergeron","year":"2001","journal-title":"Anesthesiology"},{"key":"10.1124\/dmd.115.067405_bib3","first-page":"1142","article-title":"[Adults with congenital heart diseases: a growing population, a multidisciplinary approach]","volume":"9","author":"Blanche","year":"2013","journal-title":"Rev Med Suisse"},{"key":"10.1124\/dmd.115.067405_bib4","doi-asserted-by":"crossref","first-page":"848","DOI":"10.2165\/00003495-199753050-00012","article-title":"Cisatracurium besilate. A review of its pharmacology and clinical potential in anaesthetic practice","volume":"53","author":"Bryson","year":"1997","journal-title":"Drugs"},{"key":"10.1124\/dmd.115.067405_bib5","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1093\/bja\/76.5.624","article-title":"Pharmacokinetics and pharmacodynamics of cisatracurium in patients with end-stage liver disease undergoing liver transplantation","volume":"76","author":"De Wolf","year":"1996","journal-title":"Br J Anaesth"},{"key":"10.1124\/dmd.115.067405_bib6","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1002\/rcm.1290091425","article-title":"Identification of urinary and biliary conjugated metabolites of the neuromuscular blocker 51W89 by liquid chromatography\/mass spectrometry","volume":"9","author":"Dear","year":"1995","journal-title":"Rapid Commun Mass Spectrom"},{"key":"10.1124\/dmd.115.067405_bib7","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/00000542-198607000-00002","article-title":"Elimination of atracurium in humans: contribution of Hofmann elimination and ester hydrolysis versus organ-based elimination","volume":"65","author":"Fisher","year":"1986","journal-title":"Anesthesiology"},{"key":"10.1124\/dmd.115.067405_bib8","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1007\/s00018-005-5532-2","article-title":"Insights into the genetic basis of congenital heart disease","volume":"63","author":"Garg","year":"2006","journal-title":"Cell Mol Life Sci"},{"key":"10.1124\/dmd.115.067405_bib9","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/S0140-6736(13)62145-5","article-title":"Atrial septal defects","volume":"383","author":"Geva","year":"2014","journal-title":"Lancet"},{"key":"10.1124\/dmd.115.067405_bib10","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2165\/00003088-199936010-00003","article-title":"Clinical pharmacokinetics of cisatracurium besilate","volume":"36","author":"Kisor","year":"1999","journal-title":"Clin Pharmacokinet"},{"key":"10.1124\/dmd.115.067405_bib11","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1213\/00000539-199611000-00029","article-title":"Importance of the organ-independent elimination of cisatracurium","volume":"83","author":"Kisor","year":"1996","journal-title":"Anesth Analg"},{"key":"10.1124\/dmd.115.067405_bib12","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3109\/00498254.2013.853849","article-title":"Metabolite elucidation of the Hsp90 inhibitor SNX-2112 using ultraperformance liquid chromatography\/quadrupole time-of-flight mass spectrometry (UPLC-QTOF\/MS)","volume":"44","author":"Liu","year":"2014","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.115.067405_bib13","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/j.1365-2125.2011.04149.x","article-title":"The pharmacokinetics and pharmacodynamics of cisatracurium in critically ill patients with severe sepsis","volume":"73","author":"Liu","year":"2012","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/dmd.115.067405_bib14","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1542\/pir.22.8.265","article-title":"Ventricular and atrial septal defects","volume":"22","author":"McDaniel","year":"2001","journal-title":"Pediatr Rev"},{"key":"10.1124\/dmd.115.067405_bib15","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s001010050427","article-title":"[The clinical pharmacology of cisatracurium]","volume":"46","author":"Mellinghoff","year":"1997","journal-title":"Anaesthesist"},{"key":"10.1124\/dmd.115.067405_bib16","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1111\/j.1365-2044.2009.06104.x","article-title":"Extending the WHO \u2018Safe Surgery Saves Lives\u2019 project through Global Oximetry","volume":"64","author":"Merry","year":"2009","journal-title":"Anaesthesia"},{"key":"10.1124\/dmd.115.067405_bib17","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/clpt.2008.100","article-title":"Contributions of PK\/PD modeling to intravenous anesthesia","volume":"84","author":"Minto","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.115.067405_bib18","first-page":"563","article-title":"Cisatracurium in cardiac surgery--continuous infusion vs. bolus administration","volume":"19","author":"Mirinejad","year":"2007","journal-title":"Middle East J Anaesthesiol"},{"key":"10.1124\/dmd.115.067405_bib19","first-page":"e29","article-title":"Heart disease and stroke statistics--2015 update: a report from the American Heart Association","volume":"131","author":"Mozaffarian","year":"2015","journal-title":"Circulation"},{"key":"10.1124\/dmd.115.067405_bib20","doi-asserted-by":"crossref","first-page":"46","DOI":"10.2459\/01.JCM.0000247435.67075.d0","article-title":"Septal defects: surgeons do it better","volume":"8","author":"Pace Napoleone","year":"2007","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"10.1124\/dmd.115.067405_bib21","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/S0140-6736(10)61339-6","article-title":"Ventricular septal defect","volume":"377","author":"Penny","year":"2011","journal-title":"Lancet"},{"key":"10.1124\/dmd.115.067405_bib22","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/BF03017852","article-title":"Magnesium potentiates neuromuscular blockade with cisatracurium during cardiac surgery","volume":"50","author":"Pinard","year":"2003","journal-title":"Can J Anaesth"},{"key":"10.1124\/dmd.115.067405_bib23","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1023\/A:1012015719694","article-title":"Prospective use of population pharmacokinetics\/pharmacodynamics in the development of cisatracurium","volume":"14","author":"Schmith","year":"1997","journal-title":"Pharm Res"},{"key":"10.1124\/dmd.115.067405_bib24","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1093\/bja\/81.3.409","article-title":"In vitro degradation of atracurium and cisatracurium at pH 7.4 and 37 degrees C depends on the composition of the incubating solutions","volume":"81","author":"Weindlmayr-Goettel","year":"1998","journal-title":"Br J Anaesth"},{"key":"10.1124\/dmd.115.067405_bib25","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/0009-9236(95)90190-6","article-title":"The in vitro degradation of cisatracurium, the R, cis-R'-isomer of atracurium, in human and rat plasma","volume":"58","author":"Welch","year":"1995","journal-title":"Clin Pharmacol Ther"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624101390?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624101390?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.115.067405","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T19:22:09Z","timestamp":1739906529000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624101390"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S0090955624101390"],"URL":"https:\/\/doi.org\/10.1124\/dmd.115.067405","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Altered Cisatracurium Pharmacokinetics and Pharmacodynamics in Patients with Congenital Heart Defects","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.115.067405","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}